Abstract:Purpose: Obesity, as defined by the CDC, is characterized by a body mass index exceeding 30. Over one third of the world's population is classified as overweight or obese. Furthermore, low back pain is currently the leading cause of disability worldwide. Patients who do not respond adequately to conservative therapy can consider more invasive procedures such as epidural steroid injections (ESI) as treatment for their low back pain. The purpose of this study was to compare the efficacy of lumbar epidural steroid injections for lumbosacral radiculopathy in individuals with obesity as defined by the CDC as BMI >30 as compared to non obese patients. The primary objectives were to examine the difference in pain relief, disability, and function using the Visual Analog Scale, Oswestry Disability Index, and PROMIS 29 profile in obese patients who underwent lumbar epidural steroid injections as compared to non-obese patients for lumbosacral radiculopathy at baseline and 3 months post injection. Results: This study is a retrospective analysis of patients who have undergone lumbar epidural steroid injections for lumbosacral radiculopathy at a single academic center. These patients underwent assessment using validated measurement scales at baseline and 3 months post ESI. Information from the UT Southwestern Spine Center outcomes registry and procedure notes were obtained to analyze pain, disability, functional outcomes from 2016 to 2021. 343 participants took part in the study. The results showed no significant difference in mean levels of ODI, VAS, or PROMIS-29 v1 0.0 scores when comparing values from baseline to 3 months in groups stratified by a BMI of <30 vs a BMI of greater than 30. Furthermore, there was no significant difference in mean levels of ODI, VAS, or PROMIS-29 v1.0 scores when comparing values from baseline to 3 months in groups further stratified by class of obesity: class 1 (BMI 30 to < 35), class 2 (BMI 35 to <40), class 3(BMI 40 or higher). Conclusion: No significant differences were discovered in outcomes in patients undergoing lumbar epidural steroid injections when stratified by BMI or by BMI class. These results have significant clinical implications. Obesity is a known risk factor for the development of low back pain. ESI is a frequently employed method to treat this pain after conservative approaches are exhausted; however, ESI in obese patients typically are associated with more radiation exposure and increased technical difficulty. This study indicates that obesity does not greatly affect the efficacy of lumbar epidural steroid injections. Obesity should not be a strict contraindication to lumbar ESI. In addition, the results can guide clinicians in a well-informed shared decision-making discussion with obese patients regarding the risks and potential benefits of lumbar ESI.

Comparison of functional outcomes and patient satisfaction in patients with lumbar canal stenosis with and without concomitant obesity following lumbar decompression surgery and their correlation with BMI

Efficacy of endoscopic decompression surgery for treatment of lumbar spinal stenosis

Full-endoscopic technique mitigates obesity-related perioperative morbidity of minimally invasive lumbar decompression

Effect of Obesity on Outcome of Posterior Lumbar Surgery

The Impact of Obesity on Postoperative and Perioperative Outcomes in Lumbar Spine Surgery, a Systematic Review and Meta Analysis

Do obese patients undergoing surgery for grade 1 spondylolisthesis have worse outcomes at 5 years' follow-up? A QOD study

Does obesity and varying body mass index affect the clinical outcomes and safety of biportal endoscopic lumbar decompression? A comparative cohort study

Operative outcomes of decompression in degenerative lumbar canal stenosis

Impact of obesity on adult spinal deformity (ASD) long-segment spinal fusion radiographic and clinical outcomes

Associations of overweight/obesity with patient-reported outcome measures after oblique lumbar interbody fusion

Do Obese Patients Have Worse Outcomes in Adult Spinal Deformity Surgeries? A Meta-Analysis

Obesity may be associated with adjacent-segment degeneration after single-level transforaminal lumbar interbody fusion in spinopelvic-mismatched patients with a minimum 2-year follow-up.

Complications and outcomes of open posterior lumbar spinal fusion surgery in obese patients: a meta-analysis

Prospective study on the treatment of degenerative lumbar spinal canal stenosis: Surgical versus conservative intervention

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion in Obese Patients : A Propensity Score-Matched Study

Impact of Obesity on Restoration of Sagittal Balance and Clinical Efficacy after Posterior Lumbar Interbody Fusion.

Do class III obese patients achieve similar outcomes and satisfaction to nonobese patients following surgery for cervical myelopathy? A QOD study

Depression Identified on the Mental Component Score of the Short Form-12 Affects Health Related Quality of Life After Lumbar Decompression Surgery

Correlation between anxiety, sleep disturbance and clinical outcomes in a lumbar decompression cohort

The Effect of Body Mass Index on the Outcome of Minimally Invasive Surgery for Lumbar Spinal Stenosis Complicated with Lumbar Instability

Efficacy of lumbar epidural steroid injections for lumbosacral radiculopathy in individuals with obesity: A retrospective comparative study